1. Home
  2. SCKT vs KPRX Comparison

SCKT vs KPRX Comparison

Compare SCKT & KPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCKT
  • KPRX
  • Stock Information
  • Founded
  • SCKT 1992
  • KPRX 1998
  • Country
  • SCKT United States
  • KPRX United States
  • Employees
  • SCKT N/A
  • KPRX N/A
  • Industry
  • SCKT Computer Manufacturing
  • KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • SCKT Technology
  • KPRX Health Care
  • Exchange
  • SCKT Nasdaq
  • KPRX Nasdaq
  • Market Cap
  • SCKT 9.3M
  • KPRX 9.1M
  • IPO Year
  • SCKT 1995
  • KPRX N/A
  • Fundamental
  • Price
  • SCKT $1.13
  • KPRX $2.86
  • Analyst Decision
  • SCKT
  • KPRX Strong Buy
  • Analyst Count
  • SCKT 0
  • KPRX 1
  • Target Price
  • SCKT N/A
  • KPRX $10.00
  • AVG Volume (30 Days)
  • SCKT 16.3K
  • KPRX 1.4M
  • Earning Date
  • SCKT 07-30-2025
  • KPRX 08-08-2025
  • Dividend Yield
  • SCKT N/A
  • KPRX N/A
  • EPS Growth
  • SCKT N/A
  • KPRX N/A
  • EPS
  • SCKT N/A
  • KPRX N/A
  • Revenue
  • SCKT $17,750,643.00
  • KPRX $20,000.00
  • Revenue This Year
  • SCKT $8.62
  • KPRX N/A
  • Revenue Next Year
  • SCKT N/A
  • KPRX N/A
  • P/E Ratio
  • SCKT N/A
  • KPRX N/A
  • Revenue Growth
  • SCKT 0.29
  • KPRX N/A
  • 52 Week Low
  • SCKT $0.91
  • KPRX $2.51
  • 52 Week High
  • SCKT $1.72
  • KPRX $4.86
  • Technical
  • Relative Strength Index (RSI)
  • SCKT 47.27
  • KPRX 42.65
  • Support Level
  • SCKT $1.08
  • KPRX $2.68
  • Resistance Level
  • SCKT $1.19
  • KPRX $3.22
  • Average True Range (ATR)
  • SCKT 0.05
  • KPRX 0.18
  • MACD
  • SCKT 0.00
  • KPRX -0.03
  • Stochastic Oscillator
  • SCKT 35.79
  • KPRX 33.21

About SCKT Socket Mobile Inc.

Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, of which the majority of the revenue is generated from the United States.

About KPRX Kiora Pharmaceuticals Inc.

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.

Share on Social Networks: